Northern Trust’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $179K | Sell |
76,087
-352
| -0.5% | -$851 | ﹤0.01% | 3976 |
|
|
2025
Q4 | $183K | Sell |
76,439
-5,185
| -6% | -$12.8K | ﹤0.01% | 4017 |
|
|
2025
Q3 | $217K | Sell |
81,624
-11,531
| -12% | -$34.1K | ﹤0.01% | 3953 |
|
|
2025
Q2 | $277K | Sell |
93,155
-116,096
| -55% | -$338K | ﹤0.01% | 3828 |
|
|
2025
Q1 | $678K | Sell |
209,251
-2,225
| -1% | -$7.67K | ﹤0.01% | 3446 |
|
|
2024
Q4 | $835K | Buy |
211,476
+27,909
| +15% | +$190K | ﹤0.01% | 3464 |
|
|
2024
Q3 | $1.42M | Buy |
183,567
+105,160
| +134% | +$691K | ﹤0.01% | 3193 |
|
|
2024
Q2 | $403K | Buy |
78,407
+3,018
| +4% | +$23.3K | ﹤0.01% | 3583 |
|
|
2024
Q1 | $613K | Sell |
75,389
-3,638
| -5% | -$20.9K | ﹤0.01% | 3491 |
|
|
2023
Q4 | $316K | Buy |
79,027
+26,279
| +50% | +$105K | ﹤0.01% | 3706 |
|
|
2023
Q3 | $217K | Buy |
52,748
+4,788
| +10% | +$24K | ﹤0.01% | 3780 |
|
|
2023
Q2 | $285K | Buy |
47,960
+41
| +0.1% | +$185 | ﹤0.01% | 3689 |
|
|
2023
Q1 | $165K | Buy |
47,919
+3,232
| +7% | +$12K | ﹤0.01% | 3923 |
|
|
2022
Q4 | $157K | Sell |
44,687
-141
| -0.3% | -$481 | ﹤0.01% | 3961 |
|
|
2022
Q3 | $162K | Buy |
44,828
+754
| +2% | +$3.55K | ﹤0.01% | 3960 |
|
|
2022
Q2 | $248K | Sell |
44,074
-109,159
| -71% | -$734K | ﹤0.01% | 3812 |
|
|
2022
Q1 | $1.32M | Sell |
153,233
-57,779
| -27% | -$580K | ﹤0.01% | 3296 |
|
|
2021
Q4 | $2.35M | Sell |
211,012
-40,239
| -16% | -$524K | ﹤0.01% | 3146 |
|
|
2021
Q3 | $3.25M | Buy |
251,251
+29,291
| +13% | +$467K | ﹤0.01% | 3014 |
|
|
2021
Q2 | $3.68M | Buy |
221,960
+1,147
| +0.5% | +$19.5K | ﹤0.01% | 3021 |
|
|
2021
Q1 | $3.79M | Sell |
220,813
-62,112
| -22% | -$1.16M | ﹤0.01% | 2912 |
|
|
2020
Q4 | $4.43M | Sell |
282,925
-21,833
| -7% | -$402K | ﹤0.01% | 2755 |
|
|
2020
Q3 | $5.82M | Buy |
304,758
+71,419
| +31% | +$1.23M | ﹤0.01% | 2432 |
|
|
2020
Q2 | $3.2M | Buy |
233,339
+62,331
| +36% | +$876K | ﹤0.01% | 2784 |
|
|
2020
Q1 | $1.82M | Sell |
171,008
-60,083
| -26% | -$978K | ﹤0.01% | 2909 |
|
|
2019
Q4 | $4.31M | Sell |
231,091
-611
| -0.3% | -$7.87K | ﹤0.01% | 2676 |
|
|
2019
Q3 | $2.42M | Buy |
231,702
+156,174
| +207% | +$1.27M | ﹤0.01% | 2997 |
|
|
2019
Q2 | $572K | Buy |
75,528
+31,752
| +73% | +$276K | ﹤0.01% | 3522 |
|
|
2019
Q1 | $483K | Sell |
43,776
-695
| -2% | -$5.63K | ﹤0.01% | 3547 |
|
|
2018
Q4 | $226K | Sell |
44,471
-400
| -0.9% | -$1.64K | ﹤0.01% | 3769 |
|
|
2018
Q3 | $142K | Sell |
44,871
-22
| -0% | -$86 | ﹤0.01% | 3949 |
|
|
2018
Q2 | $201K | Sell |
44,893
-169,733
| -79% | -$767K | ﹤0.01% | 3855 |
|
|
2018
Q1 | $1.15M | Sell |
214,626
-4,467
| -2% | -$20.6K | ﹤0.01% | 3339 |
|
|
2017
Q4 | $863K | Sell |
219,093
-19,640
| -8% | -$82.7K | ﹤0.01% | 3442 |
|
|
2017
Q3 | $1.04M | Buy |
238,733
+2,703
| +1% | +$12.8K | ﹤0.01% | 3424 |
|
|
2017
Q2 | $1.11M | Buy |
236,030
+6,051
| +3% | +$58K | ﹤0.01% | 3416 |
|
|
2017
Q1 | $3.79M | Buy |
229,979
+20,527
| +10% | +$269K | ﹤0.01% | 2719 |
|
|
2016
Q4 | $2.12M | Sell |
209,452
-2,733
| -1% | -$36.4K | ﹤0.01% | 3058 |
|
|
2016
Q3 | $2.86M | Buy |
212,185
+21,058
| +11% | +$309K | ﹤0.01% | 2867 |
|
|
2016
Q2 | $4M | Buy |
191,127
+146,442
| +328% | +$2.11M | ﹤0.01% | 2610 |
|
|
2016
Q1 | $422K | Buy |
44,685
+101
| +0.2% | +$836 | ﹤0.01% | 3503 |
|
|
2015
Q4 | $485K | Sell |
44,584
-155
| -0.3% | -$1.98K | ﹤0.01% | 3520 |
|
|
2015
Q3 | $668K | Buy |
+44,739
| New | +$783K | ﹤0.01% | 3426 |
|
Other funds holding XBIT
VCM
RC
BCM
VFT
Northern Trust's XBIT Position: Q1 2026 in Review
Northern Trust reduced its XBiotech (XBIT) stake by 0.46% in Q1 2026, selling an estimated $851 and leaving 76,087 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #3976.
Northern Trust first reported a position in XBIT in Q3 2015 and has held it in 43 quarters since. The position peaked at $5.82M in Q3 2020. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.
- Northern Trust held 76,087 shares of XBiotech worth $179K as of Q1 2026.
- Northern Trust sold 352 XBiotech shares in Q1 2026, an estimated $851.
- XBiotech made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3976 holding.
- Northern Trust first reported a position in XBiotech in Q3 2015 and has held it in 43 quarters since.
- Northern Trust's XBiotech position peaked at $5.82M in Q3 2020.
- 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.